ELAN PHARMACEUTICALS, INC.;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
SCHENK, DALE B.,MASLIAH, ELIEZER,BUTTINI, MANUEL J.,CHILCOTE, TAMIE J.,ROCKENSTEIN, EDWARD,GAMES, DORA KATE
申请号：
CA2616047
公开号：
CA2616047C
申请日:
2006.07.19
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The invention provides improved agents and methods for treatment of diseasesassociated with synucleinopathic diseases, including Lewy bodies of alpha-synuclein in the brain of a patient. Such methods entail administering agentsthat induce a beneficial immunogenic response against the Lewy body. Themethods are particularly useful for prophylactic and therapeutic treatment ofParkinson's disease.
